title: Human maternofoetal distribution of pyrimethamine-sulphadoxine.
authors.forename: T
authors.initials: T
authors.lastname: Trenque
authors.forename: C
authors.initials: C
authors.lastname: Marx
authors.forename: C
authors.initials: C
authors.lastname: Quereux
authors.forename: B
authors.initials: B
authors.lastname: Leroux
authors.forename: D
authors.initials: D
authors.lastname: Dupouy
authors.forename: P H
authors.initials: PH
authors.lastname: Dorangeon
authors.forename: H
authors.initials: H
authors.lastname: Choisy
authors.forename: J M
authors.initials: JM
authors.lastname: Pinon
mesh_terms: D000962:Antimalarials / Q000378:metabolism* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy / Q000517:prevention & control; D011739:Pyrimethamine / Q000378:metabolism* / Q000627:therapeutic use; D013413:Sulfadoxine / Q000378:metabolism* / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy
chemical_list: D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine